Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Jun;5(6):341-6.
doi: 10.1023/a:1015999309353.

Enhancement of colonic drug absorption by the paracellular permeation route

Affiliations

Enhancement of colonic drug absorption by the paracellular permeation route

M Tomita et al. Pharm Res. 1988 Jun.

Abstract

Colonic absorption of poorly absorbable cefmetazole was shown to increase considerably by the addition of 1% sodium caprate, sodium laurate, and mixed micelles composed of sodium oleate and sodium taurocholate. At 0.25%, their effects were weaker but still significant. Colonic absorption of inulin was also increased by the promoters at a concentration of 0.25%. These results suggest that there is a common route between inulin and cefmetazole absorption, i.e., the paracellular route. Sodium taurocholate, sodium caprylate, and EDTA disodium salts (EDTA-2Na) at 1% enhanced cefmetazole absorption less than caprate, laurate, or mixed micelles, but no such effect was found at 0.25%. The colonic pore radius was determined from the equivalent pore theory using an everted sac procedure. Caprate, laurate, and mixed micelles at 0.25% caused this radius to increase significantly, thus making it possible for inulin to permeate the everted sac from the mucosal to the serosal side. The effects of taurocholate, caprylate, and EDTA-2Na for increasing colonic pore sizes and the degree of inulin permeation were less than those of caprate, laurate, or mixed micelles. The change in the paracellular route is thus considered to result from the increase in pore size.

PubMed Disclaimer

References

    1. J Pharm Pharmacol. 1987 Feb;39(2):118-23 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1979 Jul;307(3):265-74 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1972;273(4):331-40 - PubMed
    1. J Pharmacol Exp Ther. 1979 Aug;210(2):237-42 - PubMed
    1. Biophys J. 1975 Jun;15(6):533-51 - PubMed

Publication types

LinkOut - more resources